Actively Recruiting
The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy
Led by Aalborg University Hospital · Updated on 2026-02-09
51
Participants Needed
1
Research Sites
41 weeks
Total Duration
On this page
Sponsors
A
Aalborg University Hospital
Lead Sponsor
N
Novo Nordisk A/S
Collaborating Sponsor
AI-Summary
What this Trial Is About
The trial is an open-label, randomized controlled trial. Patients with T2D on insulin therapy will be randomized to an intelligent telemonitoring group (intervention), a telemonitoring group (control), and a usual care group (control). Both the intelligent telemonitoring group and the telemonitoring group will use various devices at home. Hospital staff will monitor their data for three months. In the intelligent telemonitoring group, hospital staff and participants will be supported by decision-support algorithms in the management of insulin treatment.
CONDITIONS
Official Title
The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 63 18 years.
- Diagnosis of type 2 diabetes for at least 12 months before screening.
- Being treated with insulin or about to start insulin treatment.
- Willing to travel to the trial site in North Denmark for visits.
- Have internet at home and have MitID.
- Willing to use a smartphone and other trial devices.
- Signed informed consent.
- Ability to understand and read Danish.
You will not qualify if you...
- Pregnancy or breastfeeding.
- Planned major surgery during the trial period.
- Cancer diagnosis within five years before inclusion.
- Participation in other interventional trials.
- Limited literacy affecting use of trial devices.
- Worn a continuous glucose monitor less than 6 months before the trial.
- Considered unfit by the investigator to participate due to physical, cognitive, or understanding limitations.
- Treatment with mixed insulin.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Endocrinology
Aalborg, North Jutland, Denmark, 9000
Actively Recruiting
Research Team
J
Jannie Nørlev, PhD
CONTACT
S
Stine Hangaard, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here